News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,362 Results
Type
Article (2444)
Company Profile (39)
Press Release (35879)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14137)
Career Advice (77)
Deals (2082)
Drug Delivery (9)
Drug Development (4116)
Employer Resources (12)
FDA (431)
Job Trends (764)
News (20174)
Policy (1053)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (144)
Allergies (6)
Alliances (3479)
ALS (4)
Alzheimer's disease (47)
Antibody-drug conjugate (ADC) (18)
Approvals (433)
Artificial intelligence (11)
Autoimmune disease (3)
Automation (1)
Bankruptcy (12)
Best Places to Work (475)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (20)
Cancer (149)
Cardiovascular disease (5)
Career advice (64)
Career pathing (1)
CAR-T (16)
Cell therapy (48)
Cervical cancer (2)
Clinical research (3203)
Collaboration (94)
Compensation (51)
COVID-19 (180)
CRISPR (7)
C-suite (31)
Cystic fibrosis (2)
Data (123)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (465)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4251)
Editorial (3)
Employer branding (1)
Employer resources (10)
Events (6070)
Executive appointments (99)
FDA (481)
Featured Employer (3)
Funding (80)
Gene editing (14)
Gene therapy (21)
GLP-1 (60)
Government (149)
Guidances (1)
Healthcare (708)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (17)
Indications (2)
Infectious disease (185)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (990)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (4)
Labor market (4)
Layoffs (39)
Leadership (1)
Legal (212)
Liver cancer (6)
Lung cancer (15)
Lymphoma (4)
Management (6)
Manufacturing (20)
MASH (4)
Medical device (307)
Medtech (307)
Mergers & acquisitions (1166)
Metabolic disorders (34)
Multiple sclerosis (9)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (96)
NextGen: Class of 2025 (354)
Non-profit (154)
Northern California (384)
Now hiring (4)
Obesity (16)
Opinion (15)
Ovarian cancer (10)
Pain (10)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (23)
Patient recruitment (5)
Peanut (1)
People (5677)
Pharmaceutical (5)
Phase I (1377)
Phase II (1609)
Phase III (851)
Pipeline (85)
Policy (12)
Postmarket research (30)
Preclinical (601)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (24)
Real estate (421)
Recruiting (5)
Regulatory (809)
Reports (6)
Research institute (142)
Resumes & cover letters (9)
RNA editing (1)
Schizophrenia (12)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (375)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (489)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1821)
Vaccines (28)
Venture capitalists (8)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (13)
Last 7 days (87)
Last 30 days (254)
Last 365 days (2565)
2025 (866)
2024 (2613)
2023 (2861)
2022 (3758)
2021 (4049)
2020 (3478)
2019 (2065)
2018 (1560)
2017 (1800)
2016 (1630)
2015 (1841)
2014 (1371)
2013 (1189)
2012 (1397)
2011 (1332)
2010 (1182)
Location
Africa (43)
Alabama (1)
Arizona (15)
Asia (1873)
Australia (298)
California (883)
Canada (138)
China (41)
Colorado (21)
Connecticut (10)
Delaware (4)
Europe (3833)
Florida (44)
Georgia (5)
Idaho (3)
Illinois (14)
India (1)
Indiana (33)
Japan (8)
Kansas (12)
Maryland (27)
Massachusetts (318)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (72)
New York (50)
North Carolina (91)
Northern California (384)
Ohio (26)
Oklahoma (2)
Oregon (5)
Pennsylvania (54)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (375)
Tennessee (2)
Texas (75)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (54)
Wisconsin (6)
38,362 Results for "asana biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Solid Biosciences to Participate at The Citizens Life Sciences Conference
April 30, 2025
·
1 min read
Press Releases
Harvard Bioscience Announces CFO Transition
April 11, 2025
·
3 min read
Press Releases
Skye Bioscience to Participate in May Investment and Medical Conferences
April 30, 2025
·
3 min read
Drug Development
Asana BioSciences Announces Dosing of First Patient in Phase 1 Trial of ASN004, a Novel 5T4-Antibody-Drug-Conjugate
Asana BioSciences, LLC, a clinical stage biopharmaceutical company, today announced that the first patient has been dosed in a Phase 1 trial for ASN004, an antibody drug conjugate (ADC) targeting the 5T4 oncofetal antigen (trophoblast glycoprotein), that is expressed in a wide range of malignant tumors but shows very limited expression in normal tissues.
April 8, 2022
·
3 min read
Press Releases
Chromatin Bioscience Signs Collaboration Agreement with Astellas
April 14, 2025
·
2 min read
Press Releases
Octave Bioscience’s MSDA Test Proven to Provide Clinically Actionable Insights That Drive Meaningful Clinical Decisions in MS Care
April 17, 2025
·
4 min read
Press Releases
Quanterix and Akoya Biosciences Announce Amended Merger Agreement
April 29, 2025
·
10 min read
Press Releases
Keymed Biosciences Announces Annual Results of 2024
March 27, 2025
·
12 min read
Press Releases
Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors
April 2, 2025
·
5 min read
1 of 3,837
Next
